Feedback on lenvatinib and everolimus consultation

About this form

Please note:

  • You cannot save your progress. 
  • The form does not register text formatting, such as bold or hyperlinks. 
  • There is no character limit on any field. 
  • You will receive an email with a summary of your feedback when you submit the form.
Such as oncologist, pharmacist, person affected by cancer

Your feedback may be shared

When you give feedback on a consultation, your feedback becomes official information that Pharmac holds. Pharmac has legal responsibilities for how we manage this official information, under laws such as the Official Information Act and Privacy Act.

Pharmac may receive a request from people for official information, which could include your feedback. Legally, Pharmac must consider whether your feedback should be released.

We will consider your views when assessing whether the feedback has to be released.

If your feedback is proposed for release, then Pharmac will contact you, unless there is a legal reason that we can't.

Note that Pharmac collects and holds your information in line with our Privacy Statement.

Tell us if there is anything about your feedback that you would prefer wasn’t released.

Was using this form a useful way to give feedback?